金陵药业
(000919)
| 流通市值：39.54亿 | | | 总市值：39.55亿 |
| 流通股本：6.22亿 | | | 总股本：6.22亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,464,195,603.05 | 1,416,941,610.48 | 1,263,403,034.01 | 1,517,007,184.22 |
| 结算备付金 | 0 | - | 0 | 0 |
| 拆出资金 | 0 | - | 0 | 0 |
| 交易性金融资产 | 1,184,807,011.79 | 1,222,562,204.38 | 1,213,197,614.46 | 939,314,534.86 |
| 衍生金融资产 | 0 | - | 0 | 0 |
| 应收票据及应收账款 | 647,899,723.68 | 584,575,983.12 | 734,145,795.71 | 689,450,756.53 |
| 其中：应收票据 | 216,821,791.3 | 194,216,853.38 | 223,405,933.87 | 281,333,848.64 |
| 应收账款 | 431,077,932.38 | 390,359,129.74 | 510,739,861.84 | 408,116,907.89 |
| 应收款项融资 | 0 | 7,669,095.18 | 7,911,956.22 | 1,500,000 |
| 预付款项 | 12,875,096.46 | 9,066,715.92 | 6,639,716.35 | 6,245,643.03 |
| 应收保费 | 0 | - | 0 | 0 |
| 应收分保账款 | 0 | - | 0 | 0 |
| 应收分保合同准备金 | 0 | - | 0 | 0 |
| 其他应收款合计 | 4,971,548.77 | 6,139,380.35 | 5,620,053.7 | 5,424,318.18 |
| 其中:应收利息 | 0 | - | 0 | 0 |
| 应收股利 | 0 | - | 0 | 0 |
| 买入返售金融资产 | 0 | - | 0 | 0 |
| 存货 | 229,603,449.45 | 202,304,388.68 | 219,597,853.59 | 233,142,972.6 |
| 合同资产 | 0 | - | 0 | 0 |
| 一年内到期的非流动资产 | 0 | 268,535,125.58 | 289,897,789.17 | 393,026,213.81 |
| 其他流动资产 | 12,786,980.88 | 12,281,704.51 | 11,372,936.36 | 12,636,357.06 |
| 流动资产合计 | 3,557,139,414.08 | 3,730,076,208.2 | 3,751,786,749.57 | 3,797,747,980.29 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | - | 0 | 0 |
| 债权投资 | 0 | - | 0 | 0 |
| 其他债权投资 | 0 | - | 0 | 0 |
| 长期应收款 | 0 | - | 0 | 0 |
| 长期股权投资 | 61,914,431.07 | 61,131,622.87 | 60,039,583.65 | 62,374,352.09 |
| 其他权益工具投资 | 0 | - | 0 | 0 |
| 其他非流动金融资产 | 0 | - | 0 | 0 |
| 投资性房地产 | 6,839,341.67 | 7,071,386.12 | 7,306,253.26 | 7,542,654.79 |
| 固定资产 | 1,322,526,675.63 | 1,332,812,534.12 | 1,350,371,312.11 | 1,378,314,202.56 |
| 在建工程 | 97,689,098.84 | 72,338,949.28 | 51,617,481.07 | 48,161,902.57 |
| 生产性生物资产 | 512,590.59 | 546,310.92 | 580,031.25 | 613,751.58 |
| 油气资产 | 0 | - | 0 | 0 |
| 使用权资产 | 27,209,197.36 | 28,191,976.28 | 29,082,123.04 | 29,949,477.22 |
| 无形资产 | 306,881,667.81 | 310,630,525.81 | 317,749,496.48 | 322,925,287.16 |
| 开发支出 | 0 | - | 0 | 0 |
| 商誉 | 44,373,040.7 | 44,373,040.7 | 44,373,040.7 | 44,373,040.7 |
| 长期待摊费用 | 111,510,819.46 | 114,318,713.04 | 116,879,598.52 | 120,550,024.56 |
| 递延所得税资产 | 13,087,681.53 | 11,232,055.11 | 13,164,477.39 | 12,609,488.75 |
| 其他非流动资产 | 490,217,339.71 | 279,341,456.43 | 273,318,639.43 | 181,650,798.03 |
| 非流动资产合计 | 2,482,761,884.37 | 2,261,988,570.68 | 2,264,482,036.9 | 2,209,064,980.01 |
| 资产总计 | 6,039,901,298.45 | 5,992,064,778.88 | 6,016,268,786.47 | 6,006,812,960.3 |
| 流动负债: | | | | |
| 短期借款 | 0 | - | 0 | 0 |
| 向中央银行借款 | 0 | - | 0 | 0 |
| 吸收存款及同业存放 | 0 | - | 0 | 0 |
| 拆入资金 | 0 | - | 0 | 0 |
| 交易性金融负债 | 0 | - | 0 | 0 |
| 衍生金融负债 | 0 | - | 0 | 0 |
| 应付票据及应付账款 | 558,303,696.46 | 538,960,573.48 | 543,656,660.62 | 554,970,679.38 |
| 其中：应付票据 | 0 | 8,957,464.26 | 34,503,179.71 | 42,593,807.97 |
| 应付账款 | 558,303,696.46 | 530,003,109.22 | 509,153,480.91 | 512,376,871.41 |
| 预收款项 | 875,034.88 | 1,137,226.55 | 354,323.35 | 1,675,616.32 |
| 合同负债 | 19,813,992.01 | 23,180,180.31 | 33,828,589.41 | 19,568,869.74 |
| 卖出回购金融资产款 | 0 | - | 0 | 0 |
| 应付手续费及佣金 | 0 | - | 0 | 0 |
| 应付职工薪酬 | 109,258,369.5 | 86,883,335.06 | 70,059,107.58 | 98,200,182.73 |
| 应交税费 | 47,195,218.48 | 60,302,613.69 | 56,379,039.87 | 58,622,439.15 |
| 其他应付款合计 | 259,691,660.45 | 247,177,082.26 | 241,791,293.01 | 233,750,779.04 |
| 其中:应付利息 | 0 | - | 0 | 0 |
| 应付股利 | 2,240,000 | 2,240,000 | 2,240,000 | 2,917,251.4 |
| 应付分保账款 | 0 | - | 0 | 0 |
| 保险合同准备金 | 0 | - | 0 | 0 |
| 代理买卖证券款 | 0 | - | 0 | 0 |
| 代理承销证券款 | 0 | - | 0 | 0 |
| 一年内到期的非流动负债 | 8,737,094.05 | 8,737,094.05 | 8,737,094.05 | 8,737,094.05 |
| 其他流动负债 | 549,765.28 | 719,532.12 | 480,844.43 | 423,503.92 |
| 流动负债合计 | 1,004,424,831.11 | 967,097,637.52 | 955,286,952.32 | 975,949,164.33 |
| 非流动负债: | | | | |
| 长期借款 | 150,087,167.12 | 150,088,125 | 150,097,916.67 | 150,097,916.67 |
| 应付债券 | 0 | - | 0 | 0 |
| 优先股 | 0 | - | 0 | 0 |
| 永续债 | 0 | - | 0 | 0 |
| 租赁负债 | 33,579,326.31 | 33,196,922.77 | 33,337,143.71 | 32,980,748.82 |
| 长期应付款 | 0 | - | 0 | 0 |
| 长期应付职工薪酬 | 0 | - | 0 | 0 |
| 预计负债 | 0 | - | 0 | 0 |
| 递延收益 | 3,382,382.42 | 3,462,244.44 | 602,106.46 | 681,968.48 |
| 递延所得税负债 | 21,643,832.39 | 22,703,877.69 | 25,128,019.14 | 25,009,886.31 |
| 其他非流动负债 | 0 | - | 0 | 0 |
| 非流动负债合计 | 208,692,708.24 | 209,451,169.9 | 209,165,185.98 | 208,770,520.28 |
| 负债合计 | 1,213,117,539.35 | 1,176,548,807.42 | 1,164,452,138.3 | 1,184,719,684.61 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 621,924,528 | 621,924,528 | 621,924,528 | 621,924,528 |
| 其他权益工具 | 0 | - | 0 | 0 |
| 优先股 | 0 | - | 0 | 0 |
| 永续债 | 0 | - | 0 | 0 |
| 资本公积 | 1,088,273,942.59 | 1,088,273,942.59 | 1,088,273,942.59 | 1,088,273,942.59 |
| 减:库存股 | 0 | - | 0 | 0 |
| 其他综合收益 | 2,512,226.61 | 2,512,226.61 | 2,512,226.61 | 2,512,226.61 |
| 专项储备 | 159,163.02 | 131,148.08 | 195,341.22 | 142,868.31 |
| 盈余公积 | 425,449,851.55 | 425,449,851.55 | 425,449,851.55 | 425,449,851.55 |
| 一般风险准备 | 0 | - | 0 | 0 |
| 未分配利润 | 1,636,203,401.52 | 1,627,609,555.44 | 1,667,422,682.96 | 1,639,419,549.77 |
| 归属于母公司股东权益合计 | 3,774,523,113.29 | 3,765,901,252.27 | 3,805,778,572.93 | 3,777,722,966.83 |
| 少数股东权益 | 1,052,260,645.81 | 1,049,614,719.19 | 1,046,038,075.24 | 1,044,370,308.86 |
| 股东权益合计 | 4,826,783,759.1 | 4,815,515,971.46 | 4,851,816,648.17 | 4,822,093,275.69 |
| 负债和股东权益合计 | 6,039,901,298.45 | 5,992,064,778.88 | 6,016,268,786.47 | 6,006,812,960.3 |
| 公告日期 | 2026-10-26 | 2026-08-29 | 2026-04-28 | 2026-03-31 |
| 审计意见(境内) | | | | 标准无保留意见 |